针对神经调控候选者的多学科团队会议有助于患者的选择和优化

Vafi Salmasi, Mohammad Reza Rasouli, Ming C. Kao, E. Ottestad, A. Terkawi, Garret Morris, Xiang Qian, Stephen Coleman, David C. Talavera, Heather Poupore-King, Kristen Slater, Michael S. Leong
{"title":"针对神经调控候选者的多学科团队会议有助于患者的选择和优化","authors":"Vafi Salmasi, Mohammad Reza Rasouli, Ming C. Kao, E. Ottestad, A. Terkawi, Garret Morris, Xiang Qian, Stephen Coleman, David C. Talavera, Heather Poupore-King, Kristen Slater, Michael S. Leong","doi":"10.3389/fpain.2023.1331883","DOIUrl":null,"url":null,"abstract":"Psychological evaluation is required by insurance companies in the United States prior to proceeding with a spinal cord stimulation or a dorsal root ganglion stimulation trial. Since January 2017, we implemented a Multidisciplinary Team Conference for Neuromodulation in our center to facilitate the collaboration between pain physicians and psychologists and to optimize screening of neuromodulation candidates. This study aims to report the impact of this team conference on improvement of neuromodulation outcome in our center.Appropriateness of neuromodulation were discussed in the team conference after initial visit with the pain specialist and psychological evaluation. For this study, we prospectively and retrospectively collected data on neuromodulation candidates who went through the team conference and those who did not as controls.We discussed 461 patients in the team conference sessions from January 2017 to July 2023. Out of these, a spinal cord stimulator or a dorsal root ganglion stimulator trial was performed in 164 patients with 80.5% (132 cases) trial success rate leading to 140 implants. Out of these implants, 26 (18.6%) explanted and 21 (15%) required revision in 41 (29.3%) patients. We performed neuraxial neuromodulation trial for 70 patients without going through the team conference from January 2016 to July 2023 with a trial success rate of 45.7% (32 cases). In this group, 7 (21.9%) and 6 (18.8%) patients underwent explant and revision. The differences between the groups were statistically significant for trial success rate (odds ratio of 4.9 with p-value of <0.01) but not for explant (odds ratio of 0.8 with p-value of 0.627) or revision (odds ratio of 0.8 with p-value of 0.595).Implementing Multidisciplinary Team Conference increased trial success rate in our center. Team conference provides therapeutic benefit for patients, and also provides the opportunity for an educational discussion for trainees.","PeriodicalId":12641,"journal":{"name":"Frontiers in Pain Research","volume":"5 18","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of multidisciplinary team conference for neuromodulation candidates facilitates patient selection and optimization\",\"authors\":\"Vafi Salmasi, Mohammad Reza Rasouli, Ming C. Kao, E. Ottestad, A. Terkawi, Garret Morris, Xiang Qian, Stephen Coleman, David C. Talavera, Heather Poupore-King, Kristen Slater, Michael S. Leong\",\"doi\":\"10.3389/fpain.2023.1331883\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Psychological evaluation is required by insurance companies in the United States prior to proceeding with a spinal cord stimulation or a dorsal root ganglion stimulation trial. Since January 2017, we implemented a Multidisciplinary Team Conference for Neuromodulation in our center to facilitate the collaboration between pain physicians and psychologists and to optimize screening of neuromodulation candidates. This study aims to report the impact of this team conference on improvement of neuromodulation outcome in our center.Appropriateness of neuromodulation were discussed in the team conference after initial visit with the pain specialist and psychological evaluation. For this study, we prospectively and retrospectively collected data on neuromodulation candidates who went through the team conference and those who did not as controls.We discussed 461 patients in the team conference sessions from January 2017 to July 2023. Out of these, a spinal cord stimulator or a dorsal root ganglion stimulator trial was performed in 164 patients with 80.5% (132 cases) trial success rate leading to 140 implants. Out of these implants, 26 (18.6%) explanted and 21 (15%) required revision in 41 (29.3%) patients. We performed neuraxial neuromodulation trial for 70 patients without going through the team conference from January 2016 to July 2023 with a trial success rate of 45.7% (32 cases). In this group, 7 (21.9%) and 6 (18.8%) patients underwent explant and revision. The differences between the groups were statistically significant for trial success rate (odds ratio of 4.9 with p-value of <0.01) but not for explant (odds ratio of 0.8 with p-value of 0.627) or revision (odds ratio of 0.8 with p-value of 0.595).Implementing Multidisciplinary Team Conference increased trial success rate in our center. Team conference provides therapeutic benefit for patients, and also provides the opportunity for an educational discussion for trainees.\",\"PeriodicalId\":12641,\"journal\":{\"name\":\"Frontiers in Pain Research\",\"volume\":\"5 18\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Pain Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fpain.2023.1331883\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Pain Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fpain.2023.1331883","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在美国,保险公司要求在进行脊髓刺激或背根神经节刺激试验之前进行心理评估。自2017年1月起,我们在本中心实施了神经调控多学科团队会议,以促进疼痛科医生和心理医生之间的合作,并优化神经调控候选者的筛选。本研究旨在报告该团队会议对改善本中心神经调控结果的影响。在疼痛专科医生初诊和心理评估后,我们在团队会议上讨论了神经调控的适宜性。在这项研究中,我们前瞻性地和回顾性地收集了经过团队会议讨论的神经调控候选者和未经过团队会议讨论的候选者的数据作为对照。其中,164 名患者进行了脊髓刺激器或背根神经节刺激器试验,试验成功率为 80.5%(132 例),最终植入 140 个脊髓刺激器或背根神经节刺激器。在这些植入物中,有 26 个(18.6%)发生了爆炸,41 个(29.3%)患者中有 21 个(15%)需要进行翻修。从 2016 年 1 月到 2023 年 7 月,我们为 70 名患者进行了神经轴神经调控试验,没有经过团队会议,试验成功率为 45.7%(32 例)。在这组患者中,分别有 7 例(21.9%)和 6 例(18.8%)患者进行了切除和翻修。在试验成功率方面,组间差异有统计学意义(几率比为 4.9,P 值<0.01),但在切除术(几率比为 0.8,P 值为 0.627)或翻修术(几率比为 0.8,P 值为 0.595)方面,组间差异无统计学意义。团队会议为患者带来了治疗上的益处,也为受训者提供了教育讨论的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Application of multidisciplinary team conference for neuromodulation candidates facilitates patient selection and optimization
Psychological evaluation is required by insurance companies in the United States prior to proceeding with a spinal cord stimulation or a dorsal root ganglion stimulation trial. Since January 2017, we implemented a Multidisciplinary Team Conference for Neuromodulation in our center to facilitate the collaboration between pain physicians and psychologists and to optimize screening of neuromodulation candidates. This study aims to report the impact of this team conference on improvement of neuromodulation outcome in our center.Appropriateness of neuromodulation were discussed in the team conference after initial visit with the pain specialist and psychological evaluation. For this study, we prospectively and retrospectively collected data on neuromodulation candidates who went through the team conference and those who did not as controls.We discussed 461 patients in the team conference sessions from January 2017 to July 2023. Out of these, a spinal cord stimulator or a dorsal root ganglion stimulator trial was performed in 164 patients with 80.5% (132 cases) trial success rate leading to 140 implants. Out of these implants, 26 (18.6%) explanted and 21 (15%) required revision in 41 (29.3%) patients. We performed neuraxial neuromodulation trial for 70 patients without going through the team conference from January 2016 to July 2023 with a trial success rate of 45.7% (32 cases). In this group, 7 (21.9%) and 6 (18.8%) patients underwent explant and revision. The differences between the groups were statistically significant for trial success rate (odds ratio of 4.9 with p-value of <0.01) but not for explant (odds ratio of 0.8 with p-value of 0.627) or revision (odds ratio of 0.8 with p-value of 0.595).Implementing Multidisciplinary Team Conference increased trial success rate in our center. Team conference provides therapeutic benefit for patients, and also provides the opportunity for an educational discussion for trainees.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信